KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mckesson (MCK) Asset Writedowns and Impairment (2017 - 2025)

Mckesson (MCK) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with -$222.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 0.91% to -$222.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $821.0 million, a 736.43% increase, with the full-year FY2025 number at $667.0 million, up 1451.16% from a year prior.
  • Asset Writedowns and Impairment was -$222.0 million for Q4 2025 at Mckesson, down from $36.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 billion in Q4 2021 to a low of -$1.1 billion in Q1 2022.
  • A 5-year average of $65.4 million and a median of $28.0 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 885.71% in 2024, then surged 6433.33% in 2025.
  • Mckesson's Asset Writedowns and Impairment stood at $1.1 billion in 2021, then crashed by 99.83% to $2.0 million in 2022, then surged by 1300.0% to $28.0 million in 2023, then tumbled by 885.71% to -$220.0 million in 2024, then fell by 0.91% to -$222.0 million in 2025.
  • Per Business Quant, the three most recent readings for MCK's Asset Writedowns and Impairment are -$222.0 million (Q4 2025), $36.0 million (Q3 2025), and $196.0 million (Q2 2025).